Market overview
The global cell culture media market is worth USD 7.4 bn in 2026 and is forecast to reach USD 15.9 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Serum-free media is the largest by type segment.
| Scope | Liquid and powder media for culturing cells: basal media, serum-free and chemically defined media, and supplements for research, bioprocessing and cell therapy. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 6.8 bn |
| Value 2026 | USD 7.4 bn |
| Value 2036 | USD 15.9 bn |
| CAGR 2026-2036 | 8.0% |
| Volume 2026 | 236 million litres |
| Volume 2036 | 462 million litres |
| Average price 2026 | USD 31.2 per litre |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Cell Culture Media market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 7.4 bn |
| 2027 | USD 8.0 bn |
| 2028 | USD 8.6 bn |
| 2029 | USD 9.3 bn |
| 2030 | USD 10.0 bn |
| 2031 | USD 10.8 bn |
| 2032 | USD 11.7 bn |
| 2033 | USD 12.6 bn |
| 2034 | USD 13.7 bn |
| 2035 | USD 14.7 bn |
| 2036 | USD 15.9 bn |
Cell Culture Media market segmentation
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Classical media | 22.0% | 14.6% | USD 1.6 bn | 3.7% |
| Serum-free media | 30.0% | 30.4% | USD 2.2 bn | 8.1% |
| Chemically defined media | 28.0% | 29.7% | USD 2.1 bn | 8.6% |
| Specialty and stem cell media | 20.0% | 25.4% | USD 1.5 bn | 10.6% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Biopharma bioprocessing | 54.0% | 53.8% | USD 4.0 bn | 8.0% |
| Academic and research | 20.0% | 14.4% | USD 1.5 bn | 4.5% |
| Cell and gene therapy | 14.0% | 21.9% | USD 1.0 bn | 12.9% |
| Vaccines and diagnostics | 12.0% | 9.9% | USD 885 mn | 6.0% |
By formulation
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Serum-free | 34.0% | 38.0% | USD 2.5 bn | 9.2% |
| Chemically defined | 30.0% | 33.0% | USD 2.2 bn | 9.0% |
| Serum containing | 24.0% | 17.0% | USD 1.8 bn | 4.3% |
| Others formulations | 12.0% | 12.0% | USD 885 mn | 8.0% |
By form
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Liquid | 56.0% | 52.0% | USD 4.1 bn | 7.2% |
| Powder | 32.0% | 34.0% | USD 2.4 bn | 8.7% |
| Frozen and concentrates | 12.0% | 14.0% | USD 885 mn | 9.7% |
By cell type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| CHO | 34.0% | 33.0% | USD 2.5 bn | 7.7% |
| HEK and other mammalian | 22.0% | 21.0% | USD 1.6 bn | 7.5% |
| Stem cells | 16.0% | 20.0% | USD 1.2 bn | 10.4% |
| Hybridoma | 10.0% | 9.0% | USD 738 mn | 6.9% |
| Others cells | 18.0% | 17.0% | USD 1.3 bn | 7.4% |
Top 25 countries for cell culture media by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 87.0% of 2026 revenue and the 25 countries below together hold 96.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 2.7 bn | 37.0% | USD 5.4 bn | 7.2% |
| 2 | China | USD 885 mn | 12.0% | USD 2.5 bn | 11.2% |
| 3 | Germany | USD 590 mn | 8.0% | USD 1.1 bn | 6.7% |
| 4 | United Kingdom | USD 369 mn | 5.0% | USD 701 mn | 6.6% |
| 5 | Japan | USD 369 mn | 5.0% | USD 637 mn | 5.6% |
| 6 | Switzerland | USD 369 mn | 5.0% | USD 765 mn | 7.6% |
| 7 | South Korea | USD 332 mn | 4.5% | USD 828 mn | 9.6% |
| 8 | France | USD 295 mn | 4.0% | USD 558 mn | 6.6% |
| 9 | India | USD 258 mn | 3.5% | USD 780 mn | 11.7% |
| 10 | Singapore | USD 221 mn | 3.0% | USD 510 mn | 8.7% |
| 11 | Netherlands | USD 92 mn | 1.2% | USD 193 mn | 7.7% |
| 12 | Denmark | USD 81 mn | 1.1% | USD 169 mn | 7.6% |
| 13 | Italy | USD 72 mn | 1.0% | USD 148 mn | 7.5% |
| 14 | Spain | USD 66 mn | 0.9% | USD 137 mn | 7.6% |
| 15 | Australia | USD 63 mn | 0.8% | USD 131 mn | 7.6% |
| 16 | Canada | USD 62 mn | 0.8% | USD 129 mn | 7.6% |
| 17 | Belgium | USD 46 mn | 0.6% | USD 97 mn | 7.7% |
| 18 | Israel | USD 39 mn | 0.5% | USD 81 mn | 7.6% |
| 19 | Brazil | USD 38 mn | 0.5% | USD 88 mn | 8.8% |
| 20 | Taiwan | USD 32 mn | 0.4% | USD 75 mn | 9.0% |
| 21 | Ireland | USD 26 mn | 0.3% | USD 54 mn | 7.7% |
| 22 | Sweden | USD 24 mn | 0.3% | USD 49 mn | 7.7% |
| 23 | Austria | USD 23 mn | 0.3% | USD 48 mn | 7.7% |
| 24 | Russia | USD 19 mn | 0.3% | USD 45 mn | 8.8% |
| 25 | Poland | USD 18 mn | 0.2% | USD 43 mn | 8.8% |
| Rest of world | USD 259 mn | 3.5% | USD 537 mn | 7.6% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Thermo Fisher Scientific
- Merck KGaA
- Danaher
- Lonza
- Sartorius
- Cytiva
Group 2: Regional and specialist players
- Corning
- FUJIFILM Irvine Scientific
- Takara Bio
- HiMedia Laboratories
- STEMCELL Technologies
- Miltenyi Biotec
- Biowest
- Kerry
Group 3: Emerging and niche players
- PromoCell
- Bio-Techne
- PAN-Biotech
- Capricorn Scientific
- Xell AG
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the cell culture media market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.
The market is divided by type, by end use, by formulation, by form, by cell type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the cell culture media market?
The global cell culture media market is estimated at USD 6.8 bn in 2025 and USD 7.4 bn in 2026.
How fast will the cell culture media market grow?
It is forecast to reach USD 15.9 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 8.6 bn.
Which country is the largest market for cell culture media?
United States is the largest market by revenue at USD 2.7 bn in 2026, 37.0% of the global total. The three largest countries together hold 57.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 11.7% a year from 2026 to 2036.
Which cell culture media segment is largest?
In the by type split, Serum-free media is the largest segment with 30.0% of 2026 revenue.
Who are the leading cell culture media companies?
Global leaders include Thermo Fisher Scientific, Merck KGaA, Danaher, Lonza.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- RadiotherapyUSD 7.2 bn · 6.8% CAGR
- Companion DiagnosticsUSD 7.6 bn · 11.5% CAGR
- Transdermal Drug DeliveryUSD 7.6 bn · 6.0% CAGR
- Laboratory AutomationUSD 7.0 bn · 8.0% CAGR
- Infusion PumpUSD 6.9 bn · 5.2% CAGR
- Digital TherapeuticsUSD 7.9 bn · 20.0% CAGR
- Pharmaceutical ClosureUSD 7.9 bn · 5.6% CAGR
- Cleanroom ConsumableUSD 6.7 bn · 7.5% CAGR